Suchergebnisse - (Person:"Zhou, Zhiguang")

PubPharm (794)

111

Efficacy and Safety of LY2963016 Insulin Glargine in Chinese Patients with Type 1 Diabetes Previously Treated with Insulin Glargine (Lantus®) : a Post Hoc Analysis of a Randomized, Open-Label, Phase 3 Trial

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2022

von Yan, X. | Feng, C. | Lou, Y. | +1

112

Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus

enthalten in: Diabetes, obesity & metabolism | 2022

von Wang, W. | Song, X. | Lou, Y. | +3

113

Pharmaceutical compositions comprising thrombolytic peptide-tetrahydroisoquinoline conjugates

enthalten in: Europäisches Patentamt | 2022

von ZHOU ZHIGUANG

114

Stem Cell Educator therapy in type 1 diabetes : From the bench to clinical trials

enthalten in: Autoimmunity reviews | 2022

von Zhao, Y. | Knight, C. | Jiang, Z. | +15

115

Nutritional Status in Chinese Patients with Obesity Following Sleeve Gastrectomy/Roux-en-Y Gastric Bypass : A Retrospective Multicenter Cohort Study

enthalten in: Nutrients | 2022

von Zhang, C. | Chen, X. | Liu, S. | +7

116

Polypeptide for targeted inhibition of MLKL acetylation and/or derivative thereof and application thereof

enthalten in: Europäisches Patentamt | 2022

von LIU SHANSHAN | ZHOU ZHIGUANG | XIAO YANG | +5

117

Potential of PKM2 as a drug target in mouse models with type 1 diabetes mellitus

enthalten in: Immunity, inflammation and disease | 2022

von Liu, J. | Li, Z. | Huang, G. | +2

118

Application of TELSA structured education program in adults with type 1 diabetes mellitus

enthalten in: Zhonghua yi xue za zhi | 2022

von Liu, F. | Xie, Y. | Xu, R. | +5

119

Efficacy and Safety of LY2963016 Insulin Glargine in Chinese Patients with Type 1 Diabetes Previously Treated with Insulin Glargine ($ Lantus^{®} $): a Post Hoc Analysis of a Randomized, Open-Label, Phase 3 Trial

enthalten in: Diabetes therapy | 2022

von Yan, X. | Feng, C. | Lou, Y. | +1

120

Efficacy and Safety of LY2963016 Insulin Glargine in Chinese Patients with Type 1 Diabetes Previously Treated with Insulin Glargine ($ Lantus^{®} $): a Post Hoc Analysis of a Randomized, Open-Label, Phase 3 Trial

enthalten in: Diabetes therapy | 2022

von Yan, X. | Feng, C. | Lou, Y. | +1